Daiwa Securities Group’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3K | Hold |
314
| – | – | ﹤0.01% | 1187 |
|
|
2025
Q1 | $3K | Hold |
314
| – | – | ﹤0.01% | 1160 |
|
|
2024
Q4 | $3K | Hold |
314
| – | – | ﹤0.01% | 1187 |
|
|
2024
Q3 | $2K | Hold |
314
| – | – | ﹤0.01% | 1213 |
|
|
2024
Q2 | $1K | Hold |
314
| – | – | ﹤0.01% | 1274 |
|
|
2024
Q1 | $2K | Hold |
314
| – | – | ﹤0.01% | 1253 |
|
|
2023
Q4 | $3K | Hold |
314
| – | – | ﹤0.01% | 1231 |
|
|
2023
Q3 | $2K | Hold |
314
| – | – | ﹤0.01% | 1206 |
|
|
2023
Q2 | $3K | Hold |
314
| – | – | ﹤0.01% | 1205 |
|
|
2023
Q1 | $3K | Hold |
314
| – | – | ﹤0.01% | 1168 |
|
|
2022
Q4 | $3K | Buy |
314
+92
| +41% | +$879 | ﹤0.01% | 1180 |
|
|
2022
Q3 | $2K | Hold |
222
| – | – | ﹤0.01% | 1209 |
|
|
2022
Q2 | $2K | Hold |
222
| – | – | ﹤0.01% | 1213 |
|
|
2022
Q1 | $3K | Hold |
222
| – | – | ﹤0.01% | 1204 |
|
|
2021
Q4 | $4K | Buy |
+222
| New | +$4K | ﹤0.01% | 1206 |
|